Introduction
Bioaerosols -a suspension of airborne particles, contain living organisms such as viruses, bacteria, and fungi and comprise a significant portion of the air we breathe. Consequently, small amounts of bacteria in the bioaerosol can attach to wet surfaces and form biofilms, 1 which further enhance the growth of more bacteria and generate a foul odor. Furthermore, biofilms have been shown to be responsible for chronic infectious diseases in animals and humans. 2 In particular, Methylobacterium spp. and Sphingomonas spp. bacterial colonies and biofilms are commonly observed in areas with abundant moisture that are not regularly cleaned, such as the heat-transferring units in air conditioners or shower rooms. While chemicals or antibiotic chemical compounds (eg, chlorine, phenol, penicillin, cephalosporin) have been commonly utilized to remove such biofilms or bacteria, their toxicity and the development of antibiotic resistance necessitates the development of alternate remedies for the successful eradication of harmful bacteria and the prevention of biofilm formation. In particular, an enhanced level of antibacterial properties observed in nanoscale silver materials has led to increased interest in the application of silver nanomaterials in biomedical research. 5, 6 While development in fronts such as nanoscale synthesis has resulted in an increase in the surface-to-volume ratio of silver nanoparticles and, consequently, their antibacterial activity, [7] [8] [9] the mechanism behind the antibacterial property of silver remains unclear. Explanations include the production of reactive oxygen species that causes membrane damage, the degradation of cell membranes by pits due to physical contact, and dephosphorylation of key peptides in cell signaling pathways, yet a conclusive mechanism remains elusive due to contradictory findings. 10 Consequently, while the antibacterial activity of silver nanoparticles have led to their promotion for use in medical devices and various other products, their potential effects have resulted in regulatory measures from the United States Environmental Protection Agency (USEPA) in an effort to address uncontrolled usage of nanoparticles in specific forms.
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In order to resolve this issue, we hypothesized that the integration of silver nanoparticles into multi-walled carbon nanotubes (MWCNTs) would provide maximal antibacterial properties and minimal biotoxicity. Since MWCNTs have a high aspect ratio, given their nanoscale diameter and microscale length, their large surface area is adequate for the deposition of mass quantities of molecules during water filtration/disinfection. Additionally, a relatively light weight, high tensile strength, excellent electrical conductivity, and chemical and thermal stability are some of the unique properties of carbon nanotubes when compared to other carbon families such as diamond and charcoal. 12 Furthermore, both single-walled carbon nanotubes and MWCNTs have been reported to have antibacterial activity; 13 although the antibacterial activity of MWCNTs is inferior to that of single-walled carbon nanotubes, the economical advantages of MWCNTs are superior.
In this study, we combined silver nanomaterials with MWCNTs and expected to see a synergistic increase in antibacterial activity against Methylobacterium spp. and Sphingomonas spp. bacteria. By loading silver nanoparticles onto nanotubes, we anticipated that the resulting AgMWCNTs could be optimized for minimal absorption into the body or excretion into the environment. Furthermore, while previous reports on the preparation of Ag-MWCNTs detail a lengthy synthesis protocol with many complicated steps, [14] [15] [16] [17] we replaced the usage of environmentally hazardous reductants (eg, NaBH 4 , formamide, dimethyloformamide, or hydrazine) with ethyl alcohol for a simplified protocol. Using our modified protocol, we decreased the synthesis duration and minimized MWCNT degradation during the transformation of Ag ions to Ag nanoparticles on the surface of the nanotubes. Finally, following characterization of the prepared Ag-MWCNTs, we determined a minimum amount of Ag-MWCNTs required to prevent the growth of Methylobacterium spp. and Sphingomonas spp. while maintaining biocompatibility to mammalian cells.
Experimental methods

Acid treatment of MWCNTs
MWCNTs (40-60 nm in diameter, 5-15 μm in length) were purchased from Tokyo Chemical Industry Co., LTD., (Tokyo, Japan). Thirty milligrams of the MWCNTs were immersed in a 3:1 (vol/vol) mixture of H 2 SO 4 and HNO 3 , and then subsequently sonicated for 1 hour to produce acidified carbon nanotubes (MWCNTs-COOH). Oxidized nanotubes were later washed with deionized water until the pH of the washing buffer reached seven.
Decoration of silver nanoparticles onto MWCNTs
Ten milligrams of MWCNTs-COOH and 2 mL of 0.1 M silver nitrate solutions were each dispersed in 6 mL of ethanol and sonicated for 1 hour. The solutions were then mixed and sonicated for 1 hour to decorate the silver nanoparticles onto the MWCNTs. The resulting Ag-MWCNT samples were washed with deionized water and dried under a vacuum at 120°C overnight.
Characterization
The Ag-MWCNTs were characterized by transmission electron microscopy (TEM), X-ray diffraction (XRD), and energy-dispersive X-ray spectroscopy (EDS). XRD patterns of the products were recorded on a Rigaku D/MAX 2500 (Tokyo, Japan) using Cu Kα photon source (40 kV, 100 mA).
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Antibacterial Ag-MWCNTs TEM and high-resolution TEM images were obtained using a JEOL (Tokyo, Japan) JEM-2100F microscope equipped with an EDS detector at an acceleration voltage of 200 kV. The TEM and EDS samples were prepared by drying a droplet of the Ag-MWCNT suspension on 300 mesh-size carbon film-coated copper grid.
Antibacterial tests
The antibacterial activity of the Ag-MWCNTs was evaluated against Methylobacterium spp. (Korea Collection for Type Cultures Daejeon Korea 12618, Daejeon, Korea) and Sphingomonas spp. (KCTC 12898) bacteria. One-hundredmicroliter volumes of each type of bacteria were inoculated in R2A broth (MBcell, Los Angeles, CA, USA) and subsequently incubated with untreated control, methanol, 1,000 μg/ mL MWCNTs-COOH, 50 μg/mL Ag-MWCNTs, 40 μg/mL Ag-MWCNTs, 30 μg/mL Ag-MWCNTs, or 20 μg/mL AgMWCNTs. After incubation under shaking conditions (180 rpm) at 30°C for 32 hours, 100 μL duplicate samples of decimal dilutions were spread on R2A agar (MBcell) plates. After incubation at 30°C for 48 hours, the colonies on the plates were counted. All experiments were performed in triplicate.
Zone of inhibition test
The zone of inhibition assay on agar plates was used to determine the inhibition zone of Ag-MWCNTs against Methylobacterium spp. (KCTC 12618) and Sphingomonas spp. (KCTC 12898) bacteria. Samples were cut into paper discs and then placed on R2A plates previously inoculated with 100 μL of inoculum containing approximately 10 7 -10 8 CFU mL -1 of cultured bacteria. The plates were incubated at 30°C for 48 hours and then the diameters of the inhibition zones around the Ag-MWCNTs were determined.
Cytotoxicity test
The effects of Ag-MWCNTs on the viability of mouse liver hepatocytes (AML 12; Chungnam University, Daejeon Korea) and human peripheral blood mononuclear cells (PBMCs) (American Type Culture Collection [ATCC], Manassas, VA, USA) were evaluated using a trypan blue exclusion assay and a LIVE/DEAD ® Viability/Cytotoxicity Kit. Cultured AML 12 cells and human PBMCs were plated in six-well plates (1×10 5 cells per well) in Dulbecco's Modified Eagle's Medium (DMEM) and Roswell Park Memorial Institute medium (RPMI), respectively, each supplemented with 10% (v/v) fetal bovine serum and 1% sterile antibiotic. The cells were cultured at 37°C in a humidified atmosphere of 5% CO 2 /95% air for 8-12 hours. Subsequently, untreated control, methanol or dimethyl sulfoxide (DMSO), and 30 or 40 μg/mL Ag-MWCNTs, were added to the cells in a serumfree medium and cultured for 4-8 hours. Results are quantified as relative values to that of the negative control, where the negative control (untreated) is set to 100% viability. All experiments were performed in triplicate.
Statistical analysis
One-tailed Mann-Whitney U-test were performed using GraphPad Prism (v 5 for Mac OS X; GraphPad Software, Inc., La Jolla, CA, USA). Figure 1 summarizes the preparation of Ag-MWCNTs and the evaluation of their antibacterial activities. Treatment of MWCNTs with an acid mixture of H 2 SO 4 and HNO 3 produced oxygen-containing functional groups (eg, OH, C=O, COOH) with nominal damage to the structure of the nanotubes. 18 Silver nanoparticles were subsequently formed on the functional groups of the nanotubes via a reduction of Ag ions by ethanol. 19 Specifically, oxygen-containing functional groups on the MWCNTs-COOH provided nucleation sites for both the homing of Ag ions and growth of evenly distributed Ag nanoparticles. 20 Indeed, the silver nanoparticles on the MWCNTs were well dispersed and evenly distributed on the surfaces of the MWCNTs as assessed by TEM (Figure 2A-C) . EDS element analysis of Ag-MWCNTs indicated that approximately 1.43% (weight percent) of the total analysis area could be attributed to Ag, presumably corresponding to the Ag nanoparticles on the Ag-MWCNTs ( Figure 2D) ; the presence of copper, chromium, and tantalum elements could be attributed to the use of 300 mesh-sized copper grids coated with carbon film. 17 Silicon present in the sample may have originated from impurities included in TEM substrates or from artifacts during sample preparation. 17, 21, 22 In addition, structural validation of the Ag and carbon nanomaterials was assessed via examination of Ag-MWCNTs and MWCNTs-COOH XRD patterns, which indicate two major diffraction peaks at 2θ=26.1° and 42.6° in the (002) and (110) planes, respectively ( Figure 2E ). The broad diffraction peak of the (002) plane can be correlated with the structural ordering of MWCNT, 23 while diffraction peaks observed at 2θ=38.08°, 44.3°, 64.46°, and 77.36° correlate to the (111), (200), (220), and (311) planes, respectively -all standard features for a face-centered cubic silver crystalline structure. 22 Finally, the average diameter of the Ag nanoparticles was approximately 4.97±0.84 nm as assessed via TEM ( Figure 2F the production of monodispersed silver nanoparticles well distributed over the entire surface of the MWCNTs. Recent studies evaluating the antibacterial potential of silver nanomaterials and silver-containing products have shown these to be particularly effective against Escherichia coli. 21, [24] [25] [26] In particular, Methylobacterium spp. and Sphingomonas spp. are the most abundant bacteria and promote biofilm formation on heat exchangers or any other surface that is difficult to clean on a regular basis. Consequently, these bacteria and biofilms, which can cause chronic diseases and an overpowering stench, are a good model for evaluating the antibacterial properties of Ag-MWCNTs. An overall summary of the antibacterial activity of Ag-MWCNTs against Methylobacterium spp. and Sphingomonas spp. is described in Figure 3A . Specifically, untreated control, methanol (a positive control), MWCNTs-COOH (1,000 μg/mL), and various concentrations of Ag-MWCNTs (50, 40, 30, and 20 μg/mL) were evaluated for their antibacterial activity by measuring the cell concentration (CFU/mL) after an incubation step and a 48-hour culture step on agar plates. In the negative control, Methylobacterium spp. and Sphingomonas spp. had an average of 4×10 9 and 1×10 8 colonies, respectively, while the positive control only contained 6×10 6 and 7×10 4 colonies, respectively. MWCNTs with -COOH groups have been reported to have 30%-50% killing efficiencies against Bacillus subtilis, Staphylococcus aureus, or E. coli using a concentration of 3 mg/mL. 13, 27 Based on the previous studies, we inferred that 1 mg/mL of MWCNT-COOHs would exhibit approximately 1%-10% killing efficiency against bacteria, which happens to be similar to that observed in the negative control. A similar number of colonies as that of the positive control were registered in groups with 20 or 30 μg/mL of Ag-MWCNTs. On the other hand, no colonies were observed in groups with 40 or 50 μg/mL Ag-MWCNTs. In subsequent studies, 30 μg/mL Ag-MWCNTs was selected as an optimal concentration of Ag-MWCNTs, in which a statistically higher killing efficiency against both Methylobacterium spp. and Sphingomonas spp. was observed compared to that of the positive control. Since our goal was to find a minimum concentration of Ag-MWCNTs required to eradicate both types of bacteria abundant in biofilms, we chose 30 μg/mL as the optimal concentration of Ag-MWCNTs.
Results and discussion
In order to confirm the antibacterial activity of Ag-MWCTs in static conditions, we measured the inhibition zone for each experimental group containing bacteria cultured in ample nutrient conditions on R2A agar plates ( Figure 3B and C) . Agar plates treated with Ag-MWCNTs yielded approximately 3 mm and 2 mm clear inhibition zones for Methylobacterium spp. and Sphingomonas spp., respectively. On the other hand, the positive control, agar plate treated with methanol -dried quickly and did not generate a clear zone of inhibition. The zone of inhibition test suggested that Ag-MWCNTs might hinder the growth of bacteria by direct contact, in which the cell membrane was ruptured and surface charge interactions between Ag-MWCNTs and the bacteria were initiated.
27-29
Based on previous studies, there is a consensus that 25-40 μg/mL of silver nanoparticles is enough to eradicate E. coli, while 12.5-25 μg/mL is sufficient to eliminate S. aureus. 8, 10, 24, 28 In addition, the killing efficiency has also been shown to be dependent on nanoparticle size; 6 μg/mL of 7 nm silver particles is sufficient to eradicate bacteria. Given this understanding, we hypothesized that a minute amount of silver particles -approximately 0. in an upregulated killing efficiency when decorated onto nanotubes ( Figure 3) . Finally, to determine whether Ag-MWCNTs are biocompatible at concentrations of antibacterial potency, we performed cytotoxicity tests evaluating the effect of AgMWCNTs on mammalian cells (Figure 4 ). Both 30 and 40 μg/mL Ag-MWCNTs, which exhibited antibacterial efficacy against Methylobacterium spp. and Sphingomonas spp., were cultured with AML 12 mouse liver hepatocytes; liver hepatocytes were chosen as a model to reflect the initial absorption and deposition of nanomaterials in the liver in vivo. In addition, human PBMCs were also treated with Ag-MWCNTs to give a broad understanding of their blood compatibility and immunogenicity. The trypan blue exclusion assay and LIVE/DEAD viability/cytotoxicity assay were chosen for this study due to the solubility of the reduced product in culture medium and the interference due to the MWCNTs when using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-based reduction assays. 29, 30 About 10% of suspended Ag-MWCNTs in culture media were found in aggregates and precipitated within 6-8 hours post-introduction to the wells.
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Seo et al Treatment of AML 12 cells with both 30 and 40 μg/mL Ag-MWCNTs showed comparable cytotoxicity to that of the negative control; treatment of cells with 40 μg/mL Ag-MWCNTs did show a visible increased level of cytotoxicity. Also, the addition of methanol in the positive control eliminated most of the bacteria cells ( Figure 4A ). Representative images of calcein AM-stained live cells (green) and ethidium homodimer-stained dead cells (red) are shown in Figure 4C -F. The treatment of human PBMCs with Ag-MWCNTs, however, showed a visibly different result. While human PBMCs treated with 30 μg/mL of Ag-MWCNTs maintained a live cell percentage statistically comparable to that of the negative control, those cultured with 40 μg/mL of Ag-MWCNTs showed a significantly decreased live cell percentage that was similar to that of the positive control ( Figure 4B ). Representative images of fluorescently labeled live and dead human PBMCs are displayed in Figure 4G -J. Previous cytotoxicity studies on silver nanoparticles evaluated the allowable amount of particles to eukaryotic cells from 10 to 100 μg/mL. There has been no consensus, however, on the maximum amount of silver nanoparticles allowable for use in human trials. In this study, the amount of silver nanoparticles included in the 30 μg/mL of Ag-MWCNTs was estimated as 0.4 μg/mL on average that was regarded as biocompatible to the mammalian cells, as reported in previous studies.
31 -33 While we were not certain as to why 40 μg/mL of Ag-MWCNTs showed significant toxicity to the human PBMCs, we hypothesized that the nonattachment of PBMCs to the bottom of culture plates might have increased the likelihood of Ag-MWCNT contact during culture.
It is also interesting to note that the Ag-MWCNTs showed cytotoxicity only toward bacteria at 30 μg/mL. In light of a previous report, 11 which states that eukaryotic cells (eg, mammalian cells) require a higher concentration of silver nanomaterials to induce cytotoxicity than that required by prokaryotic cells (eg, bacteria) due to their increased complexity in function and increased size, our results are not surprising. In essence, Ag-MWCNTS effectively kill bacterial cells while exhibiting no significant cytotoxicity on mammalian cells.
Detailed toxicity studies of silver nanoparticles with a variety of cell types under different culture conditions are potential future studies, which may shed light on the mechanism of Ag-MWCNT interaction with cells. It should be noted, however, that our work only concerns the direct contact between Ag-MWCNTs and cells in vitro. Future work on in vivo validation of our hybrid nanostructures would be helpful towards recognizing potential toxicity and antibacterial function in clinical applications.
Conclusion
In this study, we suggested a simple method for the preparation of MWCNTs decorated with Ag nanoparticles, which may increase the antibacterial activity of nanomaterials and may minimize the potential uncontrolled absorption of silver nanoparticles in the body. We demonstrated that 30 μg/mL of synthesized Ag-MWCNTs yielded an efficient level of antibacterial activity against Methylobacterium spp. and Sphingomonas spp. with negligible cytotoxicity to mammalian liver cells. While Ag-MWCNTs will require significant technical advancements as well as biosafety assessments for expansion towards the commercial sector, we anticipate that the use of ethanol as a reducing agent may help in the production of environmentally friendly and inexpensive Ag-MWCNTs.
